AnaptysBio, Inc. ANAB Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | -$145.23M+11.2% | -$163.62M-27.1% | -$128.72M-123% | ||
| $559K-7.8% | $606K-7.1% | $652K-3.4% | $675K+9.0% | ||
| $36.07M+5.9% | $34.05M+2.5% | $33.21M+21.4% | $27.36M+78.2% | ||
| $19.7M+115% | -$135.34M-12.0% | -$120.8M-64.1% | -$73.59M— | ||
| $87K-75.7% | $358K-55.6% | $807K+125% | $358K-73.8% | ||
| $228.03M— | —— | —— | -$416.34M— | ||
| $68.63M+14,950% | $456K— | —— | $0— | ||
| -$132.61M-204% | $127.05M+314% | -$59.3M-235% | $44.02M-82.6% | ||
| $115.12M— | —— | —— | -$437.18M-278% | ||
| $19.61M+114% | -$135.7M-11.6% | -$121.61M-64.4% | -$73.95M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AnaptysBio, Inc.'s cash flow data come from?
- Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.